Search details
1.
Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226).
Biomarkers
; 28(3): 313-322, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36647745
Results
1 -
1
de 1
1
Next >
>>